Igdem, S. Et Al. 2012. Pretreatment SUVmax as a Prognostic Factor in Patients With Nasopharyngeal Cancer Treated With IMRT. 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) , (Massachusetts, United States Of America).

Igdem, S., Altun, M., Alco, G., Ercan, T., Unalan, B., Turkan, S., ... Okkan, S.(2012). Pretreatment SUVmax as a Prognostic Factor in Patients With Nasopharyngeal Cancer Treated With IMRT . 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Massachusetts, United States Of America

Igdem, S. Et Al. "Pretreatment SUVmax as a Prognostic Factor in Patients With Nasopharyngeal Cancer Treated With IMRT," 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Massachusetts, United States Of America, 2012

Igdem, S. Et Al. "Pretreatment SUVmax as a Prognostic Factor in Patients With Nasopharyngeal Cancer Treated With IMRT." 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) , Massachusetts, United States Of America, 2012

Igdem, S. Et Al. (2012) . "Pretreatment SUVmax as a Prognostic Factor in Patients With Nasopharyngeal Cancer Treated With IMRT." 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO) , Massachusetts, United States Of America.

@conferencepaper{conferencepaper, author={S. Igdem Et Al. }, title={Pretreatment SUVmax as a Prognostic Factor in Patients With Nasopharyngeal Cancer Treated With IMRT}, congress name={54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)}, city={Massachusetts}, country={United States Of America}, year={2012}}